CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-12 | Wells David R. Chief Financial Officer | Grant or award · Stock Options | +7,000 | 7,000 | ||
| 2017-05-12 | Thornton Michael Milos Chief Technology Officer | Conversion | +55,020 | $1.40 | $77K | 59,987 |
| 2017-05-12 | Thornton Michael Milos Chief Technology Officer | Conversion · Convertible Promissory Note | −0 | |||
| 2017-05-12 | Thornton Michael Milos Chief Technology Officer | Grant or award · Stock Options | +313,338 | 313,338 | ||
| 2017-05-12 | Michelon Francois Roger Chief Executive Officer | Conversion | +26,544 | $1.40 | $37K | 26,544 |
| 2017-05-12 | Michelon Francois Roger Chief Executive Officer | Conversion · Convertible Promissory Note | −0 | |||
| 2017-05-12 | Michelon Francois Roger Chief Executive Officer | Grant or award · Stock Options | +307,310 | 307,310 |
Page 11 of 11 · 207 trades